Supp Figure 2 from Dual Antiangiogenesis Agents Bevacizumab Plus Trebananib, without Chemotherapy, in First-line Treatment of Metastatic Colorectal Cancer: Results of a Phase II Study

Autor:	Niall C. Tebbutt, John M. Mariadason, Effie Skrinos, Alysson Wann, Timothy J. Price, Rachel Wong, Stephen Brown, Geoffrey Chong, Jessica Da Gama Duarte, Peter Savas, Fiona Chionh, Jennifer Mooi
Rok vydání:	2023
DOI:	10.1158/1078-0432.22483947
Popis:	Supplementary Fig 2. Change in overall (A) and specific (B) plasma antibody titres against tumour antigens from baseline (D0) to 6 weeks of treatment (6W), n=8 patients.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a93307e3f49119d12ba7f7bd4af5b82 https://doi.org/10.1158/1078-0432.22483947 Zobrazit plný text záznamu